{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:49:45Z","timestamp":1778226585417,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.joim.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T12:23:07Z","timestamp":1691583787000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The role and advantage of traditional Chinese medicine in the prevention and treatment of COVID-19"],"prefix":"10.1016","volume":"21","author":[{"given":"Ming","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joim.2023.08.003_b0005","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. (2023-04) [2023-04-05]. https:\/\/covid19.who.int\/."},{"key":"10.1016\/j.joim.2023.08.003_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.988524","article-title":"A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants","volume":"13","author":"Dong","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.joim.2023.08.003_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.imr.2020.100489","article-title":"Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19: a pilot randomized clinical trial","volume":"9","author":"Xiong","year":"2020","journal-title":"Integr Med Res"},{"issue":"11","key":"10.1016\/j.joim.2023.08.003_b0020","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1002\/ptr.7209","article-title":"Contribution of traditional Chinese medicine combined with conventional modern medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis","volume":"35","author":"Jiang","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.joim.2023.08.003_b0025","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2147\/IDR.S389883","article-title":"Efficacy and safety of Longyizhengqi Granule in treatment of mild COVID-19 patients caused by SARS-CoV-2 Omicron variant: a prospective study","volume":"16","author":"Wang","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.joim.2023.08.003_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154665","article-title":"Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: a propensity score-matched retrospective cohort study","volume":"111","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.joim.2023.08.003_b0035","first-page":"510","article-title":"Jinyinhua Liquid at different dosage combined with modern medicine conventional treatment for common type COVID-19: a multicenter trial of 187 cases","volume":"62","author":"Hu","year":"2021","journal-title":"Zhong Yi Za Zhi"},{"key":"10.1016\/j.joim.2023.08.003_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105127","article-title":"Hanshiyi Formula, a medicine for SARS-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: a cohort study","volume":"161","author":"Tian","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joim.2023.08.003_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153612","article-title":"Traditional Chinese medicine shenhuang granule in patients with severe\/critical COVID-19: a randomized controlled multicenter trial","volume":"89","author":"Zhou","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joim.2023.08.003_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110436","article-title":"Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-CoV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a","volume":"129","author":"Zhao","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2023.08.003_b0055","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.joim.2023.08.003_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5582\/bst.2022.01220","article-title":"Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine","volume":"16","author":"Zhang","year":"2022","journal-title":"Shufeng Jiedu Capsule Biosci Trends"},{"issue":"16","key":"10.1016\/j.joim.2023.08.003_b0065","first-page":"1413","article-title":"Analysis of the traditional Chinese medicine syndromes in 2135 patients with coronavirus disease 2019","volume":"62","author":"Zheng","year":"2021","journal-title":"Zhong Yi Za Zhi"},{"key":"10.1016\/j.joim.2023.08.003_b0070","article-title":"Tianjin: TCM deeply involved in prevention, control, treatment and rehabilitation of COVID-19","volume":"6","author":"Bai","year":"2022","journal-title":"Jing Ji Can Kao Bao"},{"key":"10.1016\/j.joim.2023.08.003_b0075","unstructured":"Liu EH. Traditional Chinese medicine workers in Tianjin race against time, compete against viruses, and take practical actions to protect the safety of people\u2019s lives\u2014gather the strength of traditional Chinese medicine to fully resist Omicron. (2022-01-24) [2023-06-25]. http:\/\/www.cntcm.com.cn\/news.html?aid=190993 [Chinese]."},{"issue":"20","key":"10.1016\/j.joim.2023.08.003_b0080","first-page":"1762","article-title":"A single-arm study on the preventive effect of Chinese medicine decoction on close contacts of patients with coronavirus disease 2019","volume":"61","author":"Zhu","year":"2020","journal-title":"Zhong Yi Za Zhi"},{"issue":"2","key":"10.1016\/j.joim.2023.08.003_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106012","article-title":"Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking","volume":"56","author":"Yu","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.joim.2023.08.003_b0090","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1109\/TCBB.2020.3009099","article-title":"AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells","volume":"18","author":"Cui","year":"2021","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"key":"10.1016\/j.joim.2023.08.003_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153315","article-title":"Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19","volume":"85","author":"Zhao","year":"2021","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.joim.2023.08.003_b0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.joim.2020.03.004","article-title":"Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis","volume":"18","author":"Zhang","year":"2020","journal-title":"J Integr Med"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0105","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1093\/cid\/ciac237","article-title":"High asymptomatic carriage with the Omicron variant in South Africa","volume":"75","author":"Garrett","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.joim.2023.08.003_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111267","article-title":"The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19","volume":"137","author":"An","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"10.1016\/j.joim.2023.08.003_b0115","first-page":"3667","article-title":"Clinical observation of Xuanfei Baidu decoction in treatment of severe coronavirus disease 2019 (COVID-19)","volume":"47","author":"Li","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.joim.2023.08.003_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2021.101305","article-title":"The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: a prospective randomized controlled trial","volume":"42","author":"Luo","year":"2021","journal-title":"Eur J Integr Med"},{"issue":"3","key":"10.1016\/j.joim.2023.08.003_b0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4014\/jmb.2009.09029","article-title":"Clinical effect of traditional Chinese medicine Shenhuang granule in critically ill patients with COVID-19: a single-centered, retrospective, observational study","volume":"31","author":"Feng","year":"2021","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.joim.2023.08.003_b0130","first-page":"139","article-title":"Potential treatment of COVID-19 with traditional Chinese medicine: what herbs can help win the battle with SARS-CoV-2?","volume":"19","author":"Li","year":"2022","journal-title":"Engineering (Beijing)"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-021-00475-w","article-title":"Evaluation of the immunomodulatory effects of anti-COVID-19 TCM formulae by multiple virus-related pathways","volume":"6","author":"Qiao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41392-020-0176-0","article-title":"Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"10.1016\/j.joim.2023.08.003_b0145","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.01410-12","article-title":"Intranasal treatment with poly(I\u2022C) protects aged mice from lethal respiratory virus infections","volume":"86","author":"Zhao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.joim.2023.08.003_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.12.007","article-title":"Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol\u00ae (Poly IC:LC), in a lethal SARS-CoV-infected BALB\/c mouse model","volume":"139","author":"Kumaki","year":"2017","journal-title":"Antiviral Res"},{"issue":"13","key":"10.1016\/j.joim.2023.08.003_b0155","first-page":"3035","article-title":"Identification and attribution of chemical constituents of Qingfei Paidu decoction based on UHPLC-LTQ-Orbitrap-MS technology","volume":"45","author":"Zhou","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"6","key":"10.1016\/j.joim.2023.08.003_b0160","first-page":"1242","article-title":"Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19","volume":"45","author":"Pang","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5\u20136","key":"10.1016\/j.joim.2023.08.003_b0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1440-1681.2007.04598.x","article-title":"Endotoxin-induced acute lung injury and organ dysfunction are attenuated by pentobarbital anaesthesia","volume":"34","author":"Kao","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.1016\/j.joim.2023.08.003_b0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00134-010-2104-1","article-title":"Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation","volume":"37","author":"Weng","year":"2011","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2015.01.025","article-title":"Callicarpa japonica Thunb. reduces inflammatory responses: a mouse model of lipopolysaccharide-induced acute lung injury","volume":"26","author":"Shin","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.joim.2023.08.003_b0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pupt.2005.03.006","article-title":"Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats","volume":"19","author":"Koksel","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.joim.2023.08.003_b0185","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.intimp.2011.01.011","article-title":"Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models","volume":"11","author":"Yang","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.joim.2023.08.003_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102198","article-title":"Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury","volume":"88","author":"Liu","year":"2020","journal-title":"Cell Calcium"},{"issue":"4","key":"10.1016\/j.joim.2023.08.003_b0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00011-020-01331-3","article-title":"Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR\/HIF-1\u03b1\/VEGF signaling pathway","volume":"69","author":"Li","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.joim.2023.08.003_b0200","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2147\/DDDT.S247103","article-title":"Emodin protects against acute pancreatitis-associated lung injury by inhibiting NLPR3 inflammasome activation via Nrf2\/HO-1 signaling","volume":"14","author":"Gao","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2014.02.010","article-title":"Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats","volume":"153","author":"Tsai","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2023.08.003_b0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijbiomac.2020.07.106","article-title":"Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines","volume":"164","author":"Chen","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.joim.2023.08.003_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116740","article-title":"A review for natural polysaccharides with anti-pulmonary fibrosis properties, which may benefit to patients infected by 2019-nCoV","volume":"247","author":"Chen","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.joim.2023.08.003_b0220","unstructured":"China Association of Chinese Medicine, China Association of Rehabilitation Medicine. Combined use of traditional Chinese medicine and modern medicine during the recovery of COVID-19 patients (version 1). Tianjin Zhong Yi Yao 2020;37(5):484\u20139 [Chinese]."},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study","volume":"27","author":"Xiong","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0230","first-page":"1","article-title":"Clinical research program of traditional Chinese medicine to promote recovery of corona virus disease 2019 in recovery period","volume":"43","author":"Yan","year":"2020","journal-title":"Chengdu Zhong Yi Yao Da Xue Xue Bao"},{"issue":"5","key":"10.1016\/j.joim.2023.08.003_b0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11684-020-0801-x","article-title":"The role played by traditional Chinese medicine in preventing and treating COVID-19 in China","volume":"14","author":"Li","year":"2020","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.joim.2023.08.003_b0240","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7150\/ijms.52664","article-title":"Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19","volume":"18","author":"An","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.joim.2023.08.003_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114830","article-title":"Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: a multicentre, double-blind, and randomised controlled trial","volume":"284","author":"Chen","year":"2022","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.joim.2023.08.003_b0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jebm.12465","article-title":"Qingjin Yiqi granules for post-COVID-19 condition: a randomized clinical trial","volume":"15","author":"Pang","year":"2022","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.joim.2023.08.003_b0255","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijid.2022.07.005","article-title":"Clinical characteristics of the Omicron variant\u2014results from a Nationwide Symptoms Survey in the Faroe Islands","volume":"122","author":"Petersen","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.joim.2023.08.003_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.549117","article-title":"Positive RT-PCR test results in 420 patients recovered from COVID-19 in Wuhan: an observational study","volume":"11","author":"He","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2023.08.003_b0265","unstructured":"Wang JP. TCM against COVID-19 27: Tong Xiaolin team announces three new research results on COVID-19. (2020-03-31) [2022-03-31]. https:\/\/www.hubpd.com\/c\/2020-03-31\/954815.shtml?from=timeline&isappinstalled=0.%202020 [Chinese]."}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496423000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496423000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:53:56Z","timestamp":1761864836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496423000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2095496423000651"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2023.08.003","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and advantage of traditional Chinese medicine in the prevention and treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.","name":"copyright","label":"Copyright"}]}}